Atlas Trials

A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy

Clinical trial NCT01589718 · WITHDRAWN

Trial details

NCT number
NCT01589718
Sponsor
Greater Houston Retina Research
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy
Start date
2012-04-01
Primary completion
2014-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.